List of Tables
Table 1. Global Sicca Syndrome Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sicca Syndrome Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sicca Syndrome Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sicca Syndrome Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Sicca Syndrome Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sicca Syndrome Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sicca Syndrome Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sicca Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sicca Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sicca Syndrome Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sicca Syndrome Drug, Product Type & Application
Table 12. Global Key Manufacturers of Sicca Syndrome Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sicca Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sicca Syndrome Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sicca Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sicca Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Sicca Syndrome Drug Sales Market Share by Region (2020-2025)
Table 19. Global Sicca Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Sicca Syndrome Drug Sales Market Share by Region (2026-2031)
Table 21. Global Sicca Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sicca Syndrome Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Sicca Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sicca Syndrome Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Sicca Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sicca Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Sicca Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Sicca Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sicca Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sicca Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sicca Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Sicca Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Sicca Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sicca Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sicca Syndrome Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sicca Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Sicca Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Sicca Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sicca Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sicca Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sicca Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Sicca Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Sicca Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sicca Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sicca Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sicca Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Sicca Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Sicca Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sicca Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sicca Syndrome Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Sicca Syndrome Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Sicca Syndrome Drug Sales Market Share by Type (2020-2025)
Table 53. Global Sicca Syndrome Drug Sales Market Share by Type (2026-2031)
Table 54. Global Sicca Syndrome Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sicca Syndrome Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sicca Syndrome Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Sicca Syndrome Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Sicca Syndrome Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Sicca Syndrome Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Sicca Syndrome Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Sicca Syndrome Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Sicca Syndrome Drug Sales Market Share by Application (2020-2025)
Table 63. Global Sicca Syndrome Drug Sales Market Share by Application (2026-2031)
Table 64. Global Sicca Syndrome Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sicca Syndrome Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sicca Syndrome Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Sicca Syndrome Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Sicca Syndrome Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Sicca Syndrome Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Akari Therapeutics, Plc Company Information
Table 71. Akari Therapeutics, Plc Description and Business Overview
Table 72. Akari Therapeutics, Plc Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Akari Therapeutics, Plc Sicca Syndrome Drug Product
Table 74. Akari Therapeutics, Plc Recent Developments/Updates
Table 75. Amgen Inc. Company Information
Table 76. Amgen Inc. Description and Business Overview
Table 77. Amgen Inc. Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Amgen Inc. Sicca Syndrome Drug Product
Table 79. Amgen Inc. Recent Developments/Updates
Table 80. Ampio Pharmaceuticals, Inc. Company Information
Table 81. Ampio Pharmaceuticals, Inc. Description and Business Overview
Table 82. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product
Table 84. Ampio Pharmaceuticals, Inc. Recent Developments/Updates
Table 85. Biogen, Inc. Company Information
Table 86. Biogen, Inc. Description and Business Overview
Table 87. Biogen, Inc. Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Biogen, Inc. Sicca Syndrome Drug Product
Table 89. Biogen, Inc. Recent Developments/Updates
Table 90. Bristol-Myers Squibb Company Company Information
Table 91. Bristol-Myers Squibb Company Description and Business Overview
Table 92. Bristol-Myers Squibb Company Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Company Sicca Syndrome Drug Product
Table 94. Bristol-Myers Squibb Company Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Company Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Plc Sicca Syndrome Drug Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. MedImmune, LLC Company Information
Table 101. MedImmune, LLC Description and Business Overview
Table 102. MedImmune, LLC Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. MedImmune, LLC Sicca Syndrome Drug Product
Table 104. MedImmune, LLC Recent Developments/Updates
Table 105. Novartis AG Company Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Novartis AG Sicca Syndrome Drug Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. Redx Pharma Plc Company Information
Table 111. Redx Pharma Plc Description and Business Overview
Table 112. Redx Pharma Plc Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Redx Pharma Plc Sicca Syndrome Drug Product
Table 114. Redx Pharma Plc Recent Developments/Updates
Table 115. Toleranzia AB Company Information
Table 116. Toleranzia AB Description and Business Overview
Table 117. Toleranzia AB Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Toleranzia AB Sicca Syndrome Drug Product
Table 119. Toleranzia AB Recent Developments/Updates
Table 120. UCB S.A. Company Information
Table 121. UCB S.A. Description and Business Overview
Table 122. UCB S.A. Sicca Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. UCB S.A. Sicca Syndrome Drug Product
Table 124. UCB S.A. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Sicca Syndrome Drug Distributors List
Table 128. Sicca Syndrome Drug Customers List
Table 129. Sicca Syndrome Drug Market Trends
Table 130. Sicca Syndrome Drug Market Drivers
Table 131. Sicca Syndrome Drug Market Challenges
Table 132. Sicca Syndrome Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sicca Syndrome Drug
Figure 2. Global Sicca Syndrome Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sicca Syndrome Drug Market Share by Type: 2024 & 2031
Figure 4. BMS-986142 Product Picture
Figure 5. Belimumab Product Picture
Figure 6. Coversin Product Picture
Figure 7. Filgotinib Product Picture
Figure 8. LY-3090106 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Sicca Syndrome Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Sicca Syndrome Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Sicca Syndrome Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sicca Syndrome Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Sicca Syndrome Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Sicca Syndrome Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Sicca Syndrome Drug Report Years Considered
Figure 20. Sicca Syndrome Drug Sales Share by Manufacturers in 2024
Figure 21. Global Sicca Syndrome Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Sicca Syndrome Drug Players: Market Share by Revenue in Sicca Syndrome Drug in 2024
Figure 23. Sicca Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Sicca Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Sicca Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Sicca Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Sicca Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Sicca Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Sicca Syndrome Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Sicca Syndrome Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Sicca Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Sicca Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Sicca Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Sicca Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Sicca Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Sicca Syndrome Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Sicca Syndrome Drug by Type (2020-2031)
Figure 60. Global Sicca Syndrome Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Sicca Syndrome Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Sicca Syndrome Drug by Application (2020-2031)
Figure 63. Global Sicca Syndrome Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Sicca Syndrome Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
